Literature DB >> 29066141

Evaluation of a shoe sole UVC device to reduce pathogen colonization on floors, surfaces and patients.

T Rashid1, K Poblete2, J Amadio2, I Hasan3, K Begum2, M J Alam2, K W Garey4.   

Abstract

BACKGROUND: An ultraviolet C (UVC) decontamination device that delivers germicidal UVC radiation to the soles of shoes has become available recently. AIM: To demonstrate that shoe soles can be vectors for healthcare-associated infection, and to investigate if a UVC shoe sole decontamination device would decrease this risk effectively.
METHODOLOGY: Three bacterial strains (Staphylococcus aureus, Enterococcus faecalis and Escherichia coli) and a non-toxigenic strain of Clostridium difficile were spiked on to standardized rubber-soled shoe soles and then selected at random for UVC exposure or no UVC exposure. Experiments were performed to test the efficacy of the UVC device to decontaminate shoe soles and flooring. E. faecalis was spiked on to shoes to assess colonization of a simulated healthcare environment and patient.
RESULTS: The UVC device decreased shoe sole contamination significantly for all tested bacterial species, and decreased floor contamination significantly for all floor types and species tested (P<0.01 for all experiments). The log10 reduction was the highest for E. coli (mean±standard deviation 2.6±0.79), followed by E. faecalis (2.19±0.68), S. aureus (1.74±0.88) and C. difficile (0.42±0.54) (P<0.0001 for all analyses). Exposure of shoe soles to the UVC device decreased contamination significantly (mean log10 reduction 2.79±1.25; P<0.0001). Proportions of samples from furniture, bed and patient dummy samples decreased from 96-100% positive in controls to 5-8% positive in UVC device experiments (P<0.0001 for all analyses).
CONCLUSION: A UVC decontamination device was shown to reduce the colony-forming unit counts of relevant pathogenic organisms from shoe soles with subsequent decreased colonization of floors, healthcare equipment, furniture, beds and a patient dummy.
Copyright © 2017 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clostridium difficile; Decolonization; Enterococcus spp.; Escherichia coli; Evaluation trial; Staphylococcus aureus

Mesh:

Year:  2017        PMID: 29066141     DOI: 10.1016/j.jhin.2017.10.011

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  5 in total

1.  Molecular epidemiology of Clostridioides difficile in domestic dogs and zoo animals.

Authors:  M Jahangir Alam; Jacob McPherson; Julie Miranda; Allyson Thrall; Van Ngo; Rebecca Kessinger; Khurshida Begum; Maud Marin; Kevin W Garey
Journal:  Anaerobe       Date:  2019-06-15       Impact factor: 3.331

2.  Clostridioides difficile ribotypes isolated from domestic environment and from patients in Bangladesh.

Authors:  Mohammad Aminul Islam; Nayel D Kabir; M Moniruzzaman; Khurshida Begum; Dilruba Ahmed; A S G Faruque; Kevin W Garey; M Jahangir Alam
Journal:  Anaerobe       Date:  2019-02-19       Impact factor: 3.331

3.  Multi-country surveillance of Clostridioides difficile demonstrates high prevalence of spores in non-healthcare environmental settings.

Authors:  Jinhee Jo; Anne J Gonzales-Luna; Chris K Lancaster; Jacob K McPherson; Khurshida Begum; M Jahangir Alam; Kevin W Garey
Journal:  Anaerobe       Date:  2022-02-25       Impact factor: 2.837

4.  A Pilot Study on the Contamination of Assistance Dogs' Paws and Their Users' Shoe Soles in Relation to Admittance to Hospitals and (In)Visible Disability.

Authors:  S Jasmijn Vos; Joris J Wijnker; Paul A M Overgaauw
Journal:  Int J Environ Res Public Health       Date:  2021-01-10       Impact factor: 3.390

Review 5.  Reducing Biofilm Infections in Burn Patients' Wounds and Biofilms on Surfaces in Hospitals, Medical Facilities and Medical Equipment to Improve Burn Care: A Systematic Review.

Authors:  Roger E Thomas; Bennett Charles Thomas
Journal:  Int J Environ Res Public Health       Date:  2021-12-14       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.